These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Target size of dopamine D-1 receptors in rat corpus striatum estimated by binding of the benzazepine 3H-SCH 23390. Gredal O, Nielsen M, Hyttel J. Pharmacol Toxicol; 1987 Apr; 60(4):255-7. PubMed ID: 2954035 [Abstract] [Full Text] [Related]
6. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390. O'Boyle KM, Waddington JL. Eur J Pharmacol; 1984 Mar 02; 98(3-4):433-6. PubMed ID: 6144559 [Abstract] [Full Text] [Related]
7. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum. Thomas KL, Rose S, Jenner P, Marsden CD. Biochem Pharmacol; 1992 Jul 07; 44(1):83-91. PubMed ID: 1321631 [Abstract] [Full Text] [Related]
8. Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake. Murugaiah K, Fleminger S, Theodorou A, Jenner P, Marsden CD. Biochem Pharmacol; 1983 Sep 01; 32(17):2495-9. PubMed ID: 6684429 [Abstract] [Full Text] [Related]
9. Specific [3H]piflutixol binding to CHAPS-solubilised rat striatal preparations involves dopamine D-2 but not D-1 binding sites. Kilpatrick GJ, Jenner P, Marsden CD. J Neurochem; 1986 Feb 01; 46(2):413-21. PubMed ID: 3941314 [Abstract] [Full Text] [Related]
10. Differential affinity of dopaminergic agonists and antagonists for D1 and D2 dopamine receptors in rat striatum. Carboni E, Memo M, Spano PF. Pharmacol Res Commun; 1983 Jul 01; 15(7):697-706. PubMed ID: 6622515 [Abstract] [Full Text] [Related]
13. In situ molecular size of agonist dopamine D-2 binding sites in rat striatum. Gredal O, Nielsen M. J Neurochem; 1987 Feb 01; 48(2):364-9. PubMed ID: 3794711 [Abstract] [Full Text] [Related]
14. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors. Fleminger S, Rupniak NM, Hall MD, Jenner P, Marsden CD. Biochem Pharmacol; 1983 Oct 01; 32(19):2921-7. PubMed ID: 6138043 [Abstract] [Full Text] [Related]
15. Dopamine D1 and D2 receptors and their signal system present in coated vesicles prepared from bovine striatal tissue. Ozaki N, Moroi K, Kadota T, Suzuki S, Kadota K. J Neurochem; 1994 Feb 01; 62(2):582-91. PubMed ID: 8294921 [Abstract] [Full Text] [Related]
16. Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats. Onali P, Olianas MC, Gessa GL. Eur J Pharmacol; 1984 Mar 16; 99(1):127-8. PubMed ID: 6233165 [No Abstract] [Full Text] [Related]
17. Quantitative determination of dopamine receptor subtypes not linked to activation of adenylate cyclase in rat striatum. Huff RM, Molinoff PB. Proc Natl Acad Sci U S A; 1982 Dec 16; 79(23):7561-5. PubMed ID: 6961433 [Abstract] [Full Text] [Related]
18. Assay of dopamine receptors with [alpha-3H]flupenthixol. Huff RM, Molinoff PB. J Pharmacol Exp Ther; 1985 Jan 16; 232(1):57-61. PubMed ID: 3965700 [Abstract] [Full Text] [Related]
19. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation. Thomas KL, Rose S, Jenner P, Marsden CD. Biochem Pharmacol; 1992 Jul 07; 44(1):73-82. PubMed ID: 1321630 [Abstract] [Full Text] [Related]